Prostate-specific antigen gene expression and telomerase activity in breast cancer patients: Possible relationship to steroid hormone receptors

Oncology Research

Volumn 19, Issue 8-9, 2011, Pages 375-380

  Mohajeri, A ^a,b   Zarghami, N ^a   Pourhasan Moghadam, M ^a   Alani, B ^c   Montazeri, V ^d   Baiat, A ^d   Fekhrjou, A ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Zahravi Pharmaceutical Co   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Gene expression; Prostate specific antigen (PSA); Telomerase

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; STEROID RECEPTOR; TELOMERASE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 84255162124     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504011X13123323849636     Document Type: Article

References (24)

1. Maria, A. C.; Arturo, L. V.; Chantal, A. Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol. Cancer Ther. 5:1669-1675; 2006.
2. Zarghami, N.; Grass, L.; Diamandis, E. P. Steroid hormone regulation of prostate specific antigen expression in breast cancer. Br. J. Cancer 75:579-588; 1997.
3. Paliouras, M.; Diamandis, E. P. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res. Treat. 102:7-18; 2007.
4. Mokbel, K.; Ghilchik, M.; Williams, G.; Akbar, N.; Parris, C.; Newbold, R. The association between telomerase activity and hormone receptor status and p53 expression in breast cancer. Int. J. Surg. Investig. 1:509-516; 2000.
5. Shay, J. W.; Wright, W. E. Use of telomerase to create bioengineered tissues. Ann. NY Acad. Sci. 57:479-491; 2005.
6. Fischer, G.; Tutuncuoglu, O.; Bakhshandeh, M.; Masood, S. Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies. Diagn. Cytopathol. 10: 653-655; 2007.
7. Murillo-Ortiz, B.; Astudillo-De la Vega, H.; Castillo-Medina, S.; Malacara, I. M.; Benitez-Bribiesca, L. Telomerase actity, estrogen receplors, Bcl-2 expression in human breast cancer and treatment response. BMC Cancer 6:206; 2006.
8. Edward, R. S.; David, S. T.; Inna, C.; Eleftherios, P. D. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer. Environ. Health Perspect. 110:241-246; 2002.
9. Diana, N.; Marius, R.; Cristian, S.; Anca, C.; Andrei, A. Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer. Folia Histochem. Cytobiol. 44:165-172; 2006.
10. Sauter, E. R.; Klein, G.; Wagner-Mann, C.; Diamandis, E. P. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Cancer Detect. Prev. 28:27-31; 2004
11. Magklara, A.; Grass, L.; Diamandis, E. P. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Breast Cancer Res. Treat. 59:263-270; 2006.
12. Deguchi, T.; Doi, T.; Ehara, H.; Ito, S.; Takahashi, Y.; Nishino, Y.; Fujihiro, S.; Kawamura, T.; Komeda, H.; Horie, M. Dewction of micrometastatic prostate cancer cells in lymph nades by reverse transcriptase-polyntrase chain reaction. Cancer Res. 53(22):535-5354; 1993.
13. Okazaki, T. Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcol (DCC) assay and immunocytochemical assay. Jpn. J. Cancer Chemother. 19:361-366; 1992.
14. Diamandis, E. P.; Yu, H.; Sutherland, D. J. A. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res. Treat. 32:301-310; 1994.
15. Monne, M.; Croce, C. M.; Yu, H.; Diamandis, E. P. Molecular charazterizaticn of prostate-specific antigen mRNA expressed in breast tumors. Cancer Res. 54:6344-6347; 1998
16. Zaacic, M.; Ablin, R. J.; Ruzickova, M.; Styrtina, S.; Danihel, L.; Zaviazic, T.; Pohlodek, K.; Holoman, K. The normal female and the male breast epithelium does not express prostate-specific antigen: Preliminary immunohistochemical observations of autopsy breast tissues. Gen. Physiol. Biophys. 18:41-44; 1999.
17. Diamandis, E. P. New diagnostic applications and physiological functions of prostate specific antigen. Scand. J. Clin. Lab. Invest. 55(Suppl. 21):105-111; 1995.
18. Diamandis, E. P. Prostate-specific antigen - new applications in breast and other cancers. Anticancer Res. 16: 3983-3986; 1996.
19. Mondello, C.; Scovassi, A. I. Telomeres, telomerase and apoptosis. Biochem. Cell. Biol. 82:498-507; 2004.
20. Mokbel, K.; Williams, N.J. Telomerase and breast cancer: From diagnosis to therapy. Int. J. Surg. Investig. 2:85-88; 2000.
21. Naoki, W. Telomerase, cell immortality and cancer. Hokkaido J. Med. Sci. 76:127-132; 2001.
22. Ilvans, S.; Celik, V.; Centinaslan, I.; Calay, Z.; Ferahaman, M. Immunohistochemical analysis of prostate-specific antigen in female breast cancer. J. BUON. 9:183-186; 2004.
23. Yu, H.; Diamandis, E. P.; Sutherland, D. J. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem. 27:75-79; 1994.
24. Wang, Z.; Kyo, S.; Takakura, M.; Tanaka, M.; Yatabe, N.; Maida, Y.; Fujiwara, M.; Hayakawa, J.; Ohmichi, M.; Koike, K.; Inoue, M. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res. 60:5376-5381; 2001.